Clik here to view.
Biosimilars: Safe and Effective? Global Doctors Split on Trust
Wednesday, June 8th 2016 at 4:05pm UTC NEW YORK–(BUSINESS WIRE)– SERMO, the leading global social media network exclusively for doctors and largest health care provider polling company, announced...
View ArticleClik here to view.
Hydra Biosciences to Present at the JMP Securities Life Sciences Conference...
Wednesday, June 8th 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Hydra Biosciences, a leader in the field of Transient Receptor Potential (TRP) ion channel modulation to treat pain,...
View ArticleClik here to view.
Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone...
Wednesday, June 8th 2016 at 11:15pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products...
View ArticleClik here to view.
Gerd Binnig Awarded 2016 Kavli Prize
Wednesday, June 8th 2016 at 7:24pm UTC Founder and CTO of Definiens Recognized For Transformative Impact On Science MUNICH–(BUSINESS WIRE)– The Kavli Prize Committee has announced the award of the...
View ArticleClik here to view.
Bristol-Myers Squibb to Announce Results for Second Quarter 2016 on July 28
Thursday, June 9th 2016 at 2:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the second quarter of 2016 on Thursday, July 28, 2016. During a...
View ArticleClik here to view.
Acorda Presents Phase 1 Data on CVT-427 for Acute Treatment of Migraine at...
Thursday, June 9th 2016 at 11:00am UTC Increased bioavailability, faster absorption, and less variability in plasma concentrations of inhaled zolmitriptan CVT-427, compared to oral and nasal delivery...
View ArticleClik here to view.
BioTime to Present at the Jefferies 2016 Global Healthcare Conference
Thursday, June 9th 2016 at 11:00am UTC ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology,...
View ArticleClik here to view.
Pro Golfer Jim Furyk Teams Up With Pfizer To Raise Awareness For Pneumococcal...
Thursday, June 9th 2016 at 11:30am UTC Furyk Takes Time to Coach His Coach, His Father, and Other Adults 65 and Older About the Risk for Potentially Serious Infectious Diseases, Like Pneumococcal...
View ArticleClik here to view.
Gilead Sciences to Present at the Jefferies 2016 Healthcare Conference on...
Thursday, June 9th 2016 at 9:00pm UTC Webcast Available Through Gilead Corporate Website FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Robin L....
View ArticleClik here to view.
Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3...
Sunday, June 12th 2016 at 9:15am UTC -Results of INO-VATE ALL Trial Published in The New England Journal of Medicine- -Overall Survival Data Also Presented as a Late-Breaking Oral Presentation at EHA...
View ArticleClik here to view.
Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an...
Saturday, June 11th 2016 at 3:00pm UTC Ongoing CV Outcomes Trial of Ertugliflozin Expanded to Test for Superiority in CV Risk Reduction KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE)– Merck...
View ArticleClik here to view.
WNS Completes Value Edge Research Services Acquisition
Tuesday, June 14th 2016 at 12:00pm UTC NEW YORK & MUMBAI, India–(BUSINESS WIRE)– WNS (Holdings) Limited (WNS) (NYSE: WNS), a leading provider of global Business Process Management (BPM) services,...
View ArticleClik here to view.
Cerulean to Present at JMP Securities Life Sciences Conference
Tuesday, June 14th 2016 at 11:00am UTC WALTHAM, Mass.–(BUSINESS WIRE)– Cerulean Pharma Inc. (NASDAQ: CERU), a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced...
View ArticleClik here to view.
OPKO Health to Host Analyst & Investor Day in New York City on June 15
Tuesday, June 14th 2016 at 8:05pm UTC MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) (« OPKO » or the « Company ») announces that it will host an Analyst & Investor Day on Wednesday, June 15,...
View ArticleClik here to view.
Heron Therapeutics to Present at the JMP Securities Life Sciences Conference
Wednesday, June 15th 2016 at 12:00pm UTC REDWOOD CITY, Calif.–(BUSINESS WIRE)– Heron Therapeutics, Inc. (NASDAQ: HRTX), a biotechnology company focused on improving the lives of patients by developing...
View ArticleClik here to view.
AVEO to Present at the 2016 JMP Securities Life Science Conference
Wednesday, June 15th 2016 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– AVEO Oncology (NASDAQ:AVEO) today announced that Michael Needle, M.D., Chief Medical Officer, will present at the 2016 JMP...
View ArticleClik here to view.
Axcella to Present at the JMP Securities Life Sciences Conference
Wednesday, June 15th 2016 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Axcella Health, a biotechnology company pioneering transformative medicines for patients with conditions where disrupted...
View ArticleClik here to view.
Soterix Medical Inc. Awarded $2.5M NIH Grant to Run Phase-2 Efficacy Trial to...
Wednesday, June 15th 2016 at 12:01pm UTC NEW YORK–(BUSINESS WIRE)– Soterix Medical, Inc. (SMI), the leading non-invasive neuromodulation medical technology company, announces the award of a $2.5...
View ArticleClik here to view.
Alzheon to Present at the 2016 JMP Securities Life Sciences Conference
Thursday, June 16th 2016 at 12:00pm UTC FRAMINGHAM, Mass.–(BUSINESS WIRE)– Alzheon Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from...
View ArticleClik here to view.
Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference
Thursday, June 16th 2016 at 12:00pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on developing advanced kinase inhibitor treatments...
View Article